Xusheng Chen

Key Laboratory Of Cancer Prevention And Therapy Tianjin
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Assessing pentafecta achievement and survival of retroperitoneal robotic partial nephrectomy for anterior tumors: An update on the outcomes of a long-term follow-up.

Assessing pentafecta achievement and survival of retroperitoneal robotic partial nephrectomy for anterior tumors: An update on the outcomes of a long-term follow-up.

Journal: Urologic oncology

Published: March 14, 2025

Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer.

Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer.

Journal: Heliyon

Published: February 23, 2023

Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations.

Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations.

Journal: Cancer medicine

Published: September 01, 2022

Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma.

Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma.

Journal: Molecular carcinogenesis

Published: September 15, 2021

Lesion Size and Iodine Quantification to Distinguish Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma Using Dual-Energy Spectral Computed Tomography.

Lesion Size and Iodine Quantification to Distinguish Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma Using Dual-Energy Spectral Computed Tomography.

Journal: Journal of computer assisted tomography

Published: May 26, 2016

CT differential diagnosis of cystic nephroma and multilocular cystic renal cell carcinoma

CT differential diagnosis of cystic nephroma and multilocular cystic renal cell carcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: February 19, 2016

MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.

MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.

Journal: BJU international

Published: January 19, 2016

Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.

Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.

Journal: BJU international

Published: July 25, 2013

Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.

Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.

Journal: Urologic oncology

Published: October 30, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026